NO950211L - Vaksiner mot metazo-parasitter - Google Patents

Vaksiner mot metazo-parasitter

Info

Publication number
NO950211L
NO950211L NO950211A NO950211A NO950211L NO 950211 L NO950211 L NO 950211L NO 950211 A NO950211 A NO 950211A NO 950211 A NO950211 A NO 950211A NO 950211 L NO950211 L NO 950211L
Authority
NO
Norway
Prior art keywords
metazo
parasites
antigen
protective
antigens
Prior art date
Application number
NO950211A
Other languages
English (en)
Other versions
NO950211D0 (no
Inventor
William David Smith
Stuart Kevin Smith
Jacqueline Murray
Susan Liddell
David Patrick Knox
Original Assignee
Mallinckrodt Veterinary Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929215505A external-priority patent/GB9215505D0/en
Priority claimed from GB929217635A external-priority patent/GB9217635D0/en
Application filed by Mallinckrodt Veterinary Inc filed Critical Mallinckrodt Veterinary Inc
Publication of NO950211L publication Critical patent/NO950211L/no
Publication of NO950211D0 publication Critical patent/NO950211D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/6416—Metalloendopeptidases (3.4.24)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer nye metazo-parasittantigener, nukleinsyrer som koder disse, og deres anvendelse ved kontroll av sykdom forårsaket av helmint- og andre metazo-parasitter, særlig helmint- og artropod-parasitter i husdyr. Spesielt tilveiebringer oppfinnelsen et beskyttende metazo-parasittantigen eller antigenfragmenter, komponenter eller prekursorer derav og funksjonelt likeverdige derivater, analoger eller varianter derav, som har beskyttende antigen aktivitet mot én eller flere metazo-parasitter, idet antigenet erå kunne bindes til pepstatin og som i nativ form er et integrert membranprotein eller proteinkompleks. Det tilveiebringes også antigener som karakteriseres ved å ha aspartyl-proteinase-lignende og/eller nøytral endopeptidase-lignende aktivitet.
NO950211A 1992-07-21 1995-01-20 Vaksiner mot metazo-parasitter NO950211D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929215505A GB9215505D0 (en) 1992-07-21 1992-07-21 Vaccines
GB929217635A GB9217635D0 (en) 1992-08-19 1992-08-19 Vaccines
PCT/GB1993/001521 WO1994002169A1 (en) 1992-07-21 1993-07-20 Vaccines against metazoan parasites

Publications (2)

Publication Number Publication Date
NO950211L true NO950211L (no) 1995-01-20
NO950211D0 NO950211D0 (no) 1995-01-20

Family

ID=26301293

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950211A NO950211D0 (no) 1992-07-21 1995-01-20 Vaksiner mot metazo-parasitter

Country Status (20)

Country Link
EP (1) EP0652769B1 (no)
JP (1) JPH07509698A (no)
KR (1) KR950702435A (no)
CN (1) CN1088217A (no)
AT (1) ATE134878T1 (no)
AU (1) AU675443B2 (no)
CA (1) CA2140673A1 (no)
CZ (1) CZ14495A3 (no)
DE (1) DE69301733T2 (no)
ES (1) ES2085163T3 (no)
FI (1) FI950248L (no)
HU (1) HUT70985A (no)
IL (1) IL106407A (no)
MY (1) MY131433A (no)
NO (1) NO950211D0 (no)
NZ (1) NZ254210A (no)
PL (1) PL307170A1 (no)
TR (1) TR27329A (no)
WO (1) WO1994002169A1 (no)
ZW (1) ZW8893A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9303681D0 (en) * 1993-02-24 1993-04-14 Pitman Moore Inc Vaccines
GB9322702D0 (en) * 1993-11-03 1993-12-22 Agricultural & Food Res Vaccines
WO1995026402A1 (en) * 1994-03-25 1995-10-05 Mallinckrodt Veterinary, Inc. Vaccines against helminthic parasites
GB9406708D0 (en) * 1994-04-05 1994-05-25 Mallinckrodt Veterinary Inc Vaccines
WO1998015625A1 (de) * 1996-10-10 1998-04-16 Bayer Aktiengesellschaft Nematodenproteine, dafür kodierende dna-sequenzen, dagegen spezifische antikörper und ihre verwendung zum auffinden nematizider wirkstoffe
KR100900837B1 (ko) 2007-12-07 2009-06-04 (주)두비엘 리포펩타이드와 폴리(ｉ:ｃ)를 아쥬반트로 포함하는 강력한백신 조성물
ES2441880B1 (es) * 2012-07-06 2014-11-13 Universidad De Granada Composición basada en polipéptidos para el tratamiento de miasis
CN103014173B (zh) * 2013-01-17 2014-04-16 福建出入境检验检疫局检验检疫技术中心 一种pcr检测鉴定盖罩大蜗牛的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8619293D0 (en) * 1986-08-07 1986-09-17 Munn E A Anthelmintic agents
GB8906156D0 (en) * 1989-03-17 1989-05-04 Munn Edward A Production and use of anthelmintic agents and protective immunogens
US5525508A (en) * 1991-02-06 1996-06-11 Biotech Australia Pty Limited Haemonchus contortus vaccine

Also Published As

Publication number Publication date
IL106407A (en) 1997-09-30
IL106407A0 (en) 1993-11-15
ZW8893A1 (en) 1994-06-01
TR27329A (tr) 1995-01-12
PL307170A1 (en) 1995-05-15
HUT70985A (en) 1995-11-28
FI950248A7 (fi) 1995-01-20
WO1994002169A1 (en) 1994-02-03
KR950702435A (ko) 1995-07-29
FI950248A0 (fi) 1995-01-20
EP0652769A1 (en) 1995-05-17
CN1088217A (zh) 1994-06-22
DE69301733D1 (de) 1996-04-11
HU9500185D0 (en) 1995-03-28
AU675443B2 (en) 1997-02-06
EP0652769B1 (en) 1996-03-06
NZ254210A (en) 1996-11-26
CA2140673A1 (en) 1994-02-03
CZ14495A3 (en) 1995-09-13
MY131433A (en) 2007-08-30
JPH07509698A (ja) 1995-10-26
ES2085163T3 (es) 1996-05-16
FI950248L (fi) 1995-01-20
ATE134878T1 (de) 1996-03-15
NO950211D0 (no) 1995-01-20
DE69301733T2 (de) 1996-10-31
AU4579993A (en) 1994-02-14

Similar Documents

Publication Publication Date Title
CY1121353T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις
BR0113112A (pt) Anticorpos, de integrina antidual, composições, métodos e usos
CY1119650T1 (el) Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
DE69637481D1 (de) Aus immunisierten Xenomäusen stammende menschliche Antikörper gegen IL-8
DK0527760T3 (da) Fremgangsmåder og præparater til vaccination mod HIV
DE69940545D1 (de) Impfstoffe welche antiidiotypische antikörper enthalten, die kohlenhydrate von streptococcus gruppe b nachahmen
NO913558L (no) Fremgangsmaate ved fremstilling av xenogene antistoffer.
BR0014282A (pt) Vacinas
DE69127440D1 (de) Lebende vakzine
NO20063026L (no) Antistoffer
EP0855918A4 (en) INTERLEUKIN-15 FROM CHICKENS AND ITS USE
DE59309458D1 (de) Synthetische Peptide, Antikörper dagegen und ihre Verwendung
DE60037900D1 (de) Chlamydia antigene und entsprechende dna-fragmente und ihre verwendungen
ATE478681T1 (de) Verwendung von polyklonalen anti-hiv ziegenseren als therapeutisches mittel
Pruett et al. Antigenicity and immunogenicity of Hypoderma lineatum soluble proteins in the bovine host
DE69301733D1 (de) Impfstoffe gegen Metazoen-Parasiten
Seed Trypanosoma gambiense and T. equiperdum: Characterization of variant specific antigens
DE3851492D1 (de) Ein gattungsspezifisches Listeria-Antigen, identifiziert durch monoklonale Antikörper.
DE68928933D1 (de) Faser-hemagglutinin von b. pertussis
NO175846C (no) Fremgangsmåte for å oppnå et immunogen
DK0513565T3 (da) Monoklonale antistoffer mod plasmin-antiplasmin-komplekset, fremgangsmåde til deres fremstilling og deres anvendelse
Mills et al. Immunisation of macaques with SIV env recombinants: specificity of T cell and antibody responses and evaluation of protective efficacy
Reddehase et al. Frequency analysis of cytolytic T lymphocyte precursors (CTL‐P) generated in vivo during lethal rabies infection of mice. II. Rabies virus genus specificity of CTL‐P
DE69010897D1 (de) Verwendung von monoklonalen Antikörpern gegen B2-Mikroglobulin.
ATE145335T1 (de) Kreuzreaktive immunisierung gegen influenza

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application